A Study to Evaluate the Safety, Tolerability, Immunogenicity, and Lot Consistency of V116 in Adults 18 to 49 Years of Age (V116-004, STRIDE-4)
Clinical trial NCT05464420 · COMPLETED
Trial details
- NCT number
- NCT05464420
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-12
- Primary completion
- 2023-05-25
- Enrollment
- 2162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.